Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis

Abstract

Objective To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs.Design Systematic review and meta-analysis of prospective published and unpublished observational studies.Data sources Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction. Review methodsWe selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model. ResultsTwelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23 608 person years of follow-up. Opiate substitution treatment was associated with a 54% reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95% confidence interval 0.32 to 0.67; P<0.001). There was evidence of heterogeneity between studies (I 2 =60%, χ 2 =20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment. ConclusionOpiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment.

Associations of substance use patterns with attempted suicide among persons who inject drugs: Can distinct use patterns play a role?

“…Among heroin users, opiate substitution therapy has been linked to greater linkage with health care services (Spire et al, 2007), and a plethora of positive health and social outcomes, including reductions in drug use (Sees et al, 2000), susceptibility to infection with Human Immunodeficiency Virus (MacArthur et al, 2012), non-fatal overdose (Kerr et al, 2007) and involvement in crime (Keen et al, 2000).…”

The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom

“…Methadone and buprenorphine are effective and essential medicines for the management of opioid dependence 7, 8. Opioid substitution treatment (OST) has positive benefits across multiple outcomes on mortality risk, transmission of HIV and hepatitis C virus (HCV), HIV treatment prognosis and drug‐related crime 1, 9, 10, 11, 12, 13, 14, 15, 16. OST is highly cost‐effective, whether delivered in the community or prison 17, 18, 19.…”

Evaluation of medication-assisted treatment of opioid dependence—The physicians’ perspective

“…MAT is associated with a reduction in substance use, mortality, treatment dropouts, HIV infections, psychosocial symptom load and delinquency, and an overall increase in quality of life (Brugal et al, 2005;Cacciola, 2001;Deck et al, 2009;Feelemyer et al, 2014;MacArthur et al, 2012;Mattick et al, 2009). Most treatment studies focused on putative objective parameters, while the subjective outcomes of MAT have received less attention.…”